Skip to main content
    S

    Scienture Holdings, Inc. (SCNX)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $2.99
    +0.09 (+3.10%)

    Market Cap: $4.76M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Scienture Holdings, Inc. (SCNX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Scienture Holdings are CNS Pharmaceuticals (CNSP), Neurosense Therapeutics (NRSN) and Senti Biosciences (SNTI). By market cap, Scienture Holdings ranks 7th of the 13 companies on this page; Ensysce Biosciences (ENSC) is the largest at $8.14M.

    Peer Comparison

    SCNX's ROIC of -56.2% is above the peer median of -260.6%, and its revenue growth of 449.1% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Scienture Holdings (SCNX)$4.76MN/A3.2x0.0%-56.2%449.1%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Intelligent Bio Solutions Inc. (INBS)$5.84MN/A1.0x-269.3%N/A25.2%0.00%
    NuCana PLC (NCNA)$3.88MN/AN/A0.0%N/A0.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Peer median$4.64MN/A1.6x0.0%-260.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Scienture Holdings, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Biotechnology; the other one is in Medical Devices.

    CompanyAboutPeers
    CNS Pharmaceuticals Inc (CNSP)Biotechnology
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Neurosense Therapeutics Ltd (NRSN)Biotechnology
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    Senti Biosciences Inc (SNTI)Biotechnology
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors
    Exicure Inc (XCUR)Biotechnology
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    Skye Bioscience, Inc. Common Stock (SKYE)Biotechnology
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Intelligent Bio Solutions Inc. (INBS)Medical Devices
    Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven...
    INBS competitors
    NuCana PLC (NCNA)Biotechnology
    NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer.
    NCNA competitors
    Soligenix Inc. (SNGX)Biotechnology
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    SeaStar Medical Holding Corporation (ICU)Biotechnology
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    Ensysce Biosciences Inc (ENSC)Biotechnology
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    Creative Medical Technology Holdings Inc (CELZ)Biotechnology
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    Curis Inc (CRIS)Biotechnology
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors

    Frequently Asked Questions About SCNX

    Who are Scienture Holdings' main competitors?

    The companies most similar to Scienture Holdings include CNS Pharmaceuticals (CNSP), Neurosense Therapeutics (NRSN), Senti Biosciences (SNTI), Exicure (XCUR) and Skye Bioscience, Inc. Common Stock (SKYE), listed from the closest match.

    Who is Scienture Holdings' biggest competitor?

    Ensysce Biosciences (ENSC) is the largest of the similar companies at $8.14M; CNS Pharmaceuticals (CNSP) is the closest match by business profile, size, sector and industry.

    How does SCNX stock compare with its competitors?

    SCNX's P/S is 3.2x against a peer median of 1.6x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Scienture Holdings' competitors pays a higher dividend?

    Scienture Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Scienture Holdings bigger than its competitors?

    No. Scienture Holdings is 7th by market cap among the 13 companies on this page; the largest is Ensysce Biosciences (ENSC) at $8.14M.